Skip to content

United Therapeutics UTHR Total costs & expenses

Total costs & expenses at other companies

Insmed logo
InsmedINSM
ALN
Alnylam PharmaceuticalsALNY
Incyte logo
IncyteINCY
Amgen logo
AmgenAMGN
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN

Other financials

Income statement

See full
Revenue$781.5M-1.6%
Gross profit$648.1M-7.7%
Operating income$325.8M-14.9%
Net income$274.9M-14.7%
EPS (diluted)$5.82-12.2%

Balance sheet

See full
Cash & equivalents$1.3B-32.6%
Total equity$5.9B-13.3%
Total assets$6.7B-13.3%

Cash flow

See full
Operating cash flow$463.3M+0.5%
CapEx$100.8M+34.6%
Free cash flow$362.5M-6.2%

Valuation

See full
Market cap$23.41B+87.7%
P/E18.2×+7.9×
P/S7.4×+3.2×

Profitability

See full
Gross margin86.6%-2.4pp
Operating margin45.3%-1.6pp
Net margin40.6%+0.2pp

Returns & leverage

See full
Return on equity20.3%+0.3pp
Debt / equity
Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is United Therapeutics's total costs & expenses?
United Therapeutics (UTHR) reported total costs & expenses of $455.7M in Q1 2026.
How has United Therapeutics's total costs & expenses changed year-over-year?
United Therapeutics's total costs & expenses increased by 10.7% year-over-year, from $411.6M to $455.7M.
What is the long-term trend for United Therapeutics's total costs & expenses?
Over 4 years (2021 to 2025), United Therapeutics's total costs & expenses has grown at a 10.6% compound annual growth rate (CAGR), from $1.13B to $1.69B.